Works by Leitner, Judith


Results: 41
    1
    2
    3
    4
    5
    6

    PD‐1 blocking antibodies moonlighting as killers.

    Published in:
    European Journal of Immunology, 2021, v. 51, n. 6, p. 1361, doi. 10.1002/eji.202149276
    By:
    • Leitner, Judith;
    • Battin, Claire;
    • Grabmeier‐Pfistershammer, Katharina;
    • Steinberger, Peter
    Publication type:
    Article
    7
    8
    9

    TIM‐3 and CEACAM1 do not interact in cis and in trans.

    Published in:
    European Journal of Immunology, 2020, v. 50, n. 8, p. 1126, doi. 10.1002/eji.201948400
    By:
    • De Sousa Linhares, Annika;
    • Kellner, Florian;
    • Jutz, Sabrina;
    • Zlabinger, Gerhard J.;
    • Gabius, Hans‐Joachim;
    • Huppa, Johannes B.;
    • Leitner, Judith;
    • Steinberger, Peter
    Publication type:
    Article
    10

    The soluble cytoplasmic tail of CD45 (ct-CD45) in human plasma contributes to keep T cells in a quiescent state.

    Published in:
    European Journal of Immunology, 2017, v. 47, n. 1, p. 193, doi. 10.1002/eji.201646405
    By:
    • Puck, Alexander;
    • Hopf, Stefan;
    • Modak, Madhura;
    • Majdic, Otto;
    • Cejka, Petra;
    • Blüml, Stephan;
    • Schmetterer, Klaus;
    • Arnold‐Schrauf, Catharina;
    • Gerwien, Jens G.;
    • Frederiksen, Klaus S.;
    • Thell, Elisabeth;
    • Leitner, Judith;
    • Steinberger, Peter;
    • Aigner, Regina;
    • Seyerl‐Jiresch, Maria;
    • Zlabinger, Gerhard J.;
    • Stöckl, Johannes
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19

    TIM-3 Does Not Act as a Receptor for Galectin-9.

    Published in:
    PLoS Pathogens, 2013, v. 9, n. 3, p. 1, doi. 10.1371/journal.ppat.1003253
    By:
    • Leitner, Judith;
    • Rieger, Armin;
    • Pickl, Winfried F.;
    • Zlabinger, Gerhard;
    • Grabmeier-Pfistershammer, Katharina;
    • Steinberger, Peter
    Publication type:
    Article
    20

    Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 3029, doi. 10.1007/s00262-023-03474-8
    By:
    • Battin, Claire;
    • De Sousa Linhares, Annika;
    • Leitner, Judith;
    • Grossmann, Anna;
    • Lupinek, Daniela;
    • Izadi, Shiva;
    • Castilho, Alexandra;
    • Waidhofer-Söllner, Petra;
    • Grabmeier-Pfistershammer, Katharina;
    • Stritzker, Jochen;
    • Steinberger, Peter
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Neuropilin-1 Acts as a Receptor for Complement Split Products.

    Published in:
    Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02209
    By:
    • Battin, Claire;
    • De Sousa Linhares, Annika;
    • Paster, Wolfgang;
    • Isenman, David E.;
    • Wahrmann, Markus;
    • Leitner, Judith;
    • Zlabinger, Gerhard J.;
    • Steinberger, Peter;
    • Hofer, Johannes
    Publication type:
    Article
    32
    33
    34

    Researcher of the Month Oktober 2013.

    Published in:
    Wiener Klinische Wochenschrift, 2013, v. 125, n. 19/20, p. 637, doi. 10.1007/s00508-013-0442-z
    By:
    • Leitner, Judith
    Publication type:
    Article
    35
    36

    Discovery of the first PD-1 ligand encoded by a pathogen.

    Published in:
    Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1007334
    By:
    • Martínez-Vicente, Pablo;
    • Poblador, Francesc;
    • Leitner, Judith;
    • Farré, Domènec;
    • Steinberger, Peter;
    • Engel, Pablo;
    • Angulo, Ana
    Publication type:
    Article
    37
    38
    39
    40
    41